Delaware Chapter of the American College of CardiologyOur purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments. |
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- First-Ever Guideline Addresses CKM SyndromeThe new 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome is the first ever to address the "interrelated condition characterized by the interconnections among metabolic risk factors (including obesity and type 2 diabetes)...
- Optimizing Dual Antiplatelet Therapy in Patients With Diabetes and Multivessel Disease Undergoing PCI: The TUXEDO-2 TrialThe TUXEDO-2 (Ultrathin Strut vs. Xience in a Diabetic Population With Multivessel Disease 2—India Study) trial demonstrated that among patients with diabetes mellitus and multivessel coronary artery disease undergoing percutaneous coronary intervention (PCI)...
- ACCEL Lite: Key Take-Home Messages From the 2025 Sports Cardiology GuidelinesIn this interview, Alison L. Bailey, MD, FACC and Aaron Baggish, MD, FACC examine the latest sports cardiology guidelines.
- QI.PI Project Grant Recipient Develops Digital Biomarker For PAD ScreeningA quick, noninvasive toe-based light measurement combined with artificial intelligence demonstrated efficacy in screening for peripheral artery disease (PAD), according to a recent study published in npj Digital Medicine by a 2024 recipient of an ACC Accreditation Services' QI.PI Project Grant.
- Racial and Sex Disparities in M-TEER Outcomes | NCDR StudyBlack patients undergoing mitral transcatheter edge-to-edge repair (M-TEER) were more likely to present with more advanced disease, had lower procedural success and higher heart failure (HF) readmission rates vs. White patients, and female patients had lower procedural success rates vs. male patients...



